ATE247089T1 - Pyridoncarbonsäurederivate oder ihre salze und diese als aktive bestandteile enthaltende medikamente - Google Patents
Pyridoncarbonsäurederivate oder ihre salze und diese als aktive bestandteile enthaltende medikamenteInfo
- Publication number
- ATE247089T1 ATE247089T1 AT97946800T AT97946800T ATE247089T1 AT E247089 T1 ATE247089 T1 AT E247089T1 AT 97946800 T AT97946800 T AT 97946800T AT 97946800 T AT97946800 T AT 97946800T AT E247089 T1 ATE247089 T1 AT E247089T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- amino
- salts
- substituted
- halogen atom
- Prior art date
Links
- YSLIPUSJNFIFAB-UHFFFAOYSA-N 2-oxopyridine-1-carboxylic acid Chemical class OC(=O)N1C=CC=CC1=O YSLIPUSJNFIFAB-UHFFFAOYSA-N 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- -1 (protected) amino Chemical group 0.000 abstract 5
- 125000003545 alkoxy group Chemical group 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 5
- 125000005843 halogen group Chemical group 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP31769396 | 1996-11-28 | ||
| JP16724597 | 1997-06-24 | ||
| PCT/JP1997/004326 WO1998023592A1 (en) | 1996-11-28 | 1997-11-27 | Novel pyridonecarboxylic acid derivatives or salts thereof and drugs containing the same as the active ingredient |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE247089T1 true ATE247089T1 (de) | 2003-08-15 |
Family
ID=26491349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97946800T ATE247089T1 (de) | 1996-11-28 | 1997-11-27 | Pyridoncarbonsäurederivate oder ihre salze und diese als aktive bestandteile enthaltende medikamente |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6136823A (de) |
| EP (1) | EP0945435B1 (de) |
| JP (1) | JP3448305B2 (de) |
| KR (1) | KR100516379B1 (de) |
| AT (1) | ATE247089T1 (de) |
| CA (1) | CA2271136C (de) |
| DE (1) | DE69724140T2 (de) |
| WO (1) | WO1998023592A1 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA02000103A (es) * | 1999-07-01 | 2003-07-21 | Wakunaga Pharma Co Ltd | Derivado de acido quinolin carboxilico o sales del mismo. |
| PE20011349A1 (es) | 2000-06-16 | 2002-01-19 | Upjohn Co | 1-aril-4-oxo-1,4-dihidro-3-quinolincarboxamidas como agentes antivirales |
| US20030232059A1 (en) * | 2002-06-18 | 2003-12-18 | Ling Yuk Cheung | Feed additives for fishes |
| WO2005009971A1 (ja) | 2003-07-24 | 2005-02-03 | Astellas Pharma Inc. | キノロン誘導体又はその塩 |
| JP4853824B2 (ja) * | 2005-01-20 | 2012-01-11 | アステラス製薬株式会社 | キノロン誘導体を有効成分とする医薬組成物 |
| JP4858683B2 (ja) * | 2005-01-20 | 2012-01-18 | アステラス製薬株式会社 | キノロン誘導体又はその塩の製造法 |
| JO2323B1 (en) * | 2005-05-12 | 2006-06-28 | الجامعة الأردنية | Compounds of Pyrido [f-3,2] quinoxaline-8-carboxylic acid and its equivalents of pyrido [g-3,2] quinoxalin. |
| AU2007225088B2 (en) * | 2006-03-13 | 2012-09-13 | Kyorin Pharmaceutical Co., Ltd | Aminoquinolones as GSK-3 inhibitors |
| TWI391378B (zh) | 2006-03-16 | 2013-04-01 | Astellas Pharma Inc | 喹啉酮衍生物或其製藥學上可被容許之鹽 |
| GB2442951B (en) * | 2006-08-10 | 2011-02-23 | Univ Jordan | Anticancer and antibacterial agents |
| CA2699151A1 (en) | 2007-09-11 | 2009-03-19 | Activx Biosciences, Inc. | Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors |
| KR101597841B1 (ko) | 2007-09-12 | 2016-02-26 | 교린 세이야꾸 가부시키 가이샤 | Ｇｓｋ-３ 억제제로서의 스피로시클릭 아미노퀴놀론 |
| CA2755120C (en) | 2009-03-11 | 2017-05-16 | Kyorin Pharmaceutical Co., Ltd. | 7-cycloalkylaminoquinolones as gsk-3 inhibitors |
| CN106256824B (zh) * | 2015-06-18 | 2020-10-27 | 重庆医药工业研究院有限责任公司 | 一种高纯度德拉沙星葡甲胺盐的制备方法 |
| CA3030204A1 (en) | 2016-07-11 | 2018-01-18 | Bayer Pharma Aktiengesellschaft | 7-substituted 1-pyridyl-naphthyridine-3-carboxylic acid amides and use thereof |
| JOP20190045A1 (ar) | 2016-09-14 | 2019-03-14 | Bayer Ag | مركبات أميد حمض 1- أريل-نفثيريدين-3-كربوكسيليك مستبدلة في الموضع 7 واستخدامها. |
| EP3296298A1 (de) | 2016-09-14 | 2018-03-21 | Bayer Pharma Aktiengesellschaft | 7-substituierte 1-aryl-naphthyridin-3-carbonsäureamide und ihre verwendung |
| JOP20190086A1 (ar) | 2016-10-21 | 2019-04-18 | Novartis Ag | مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب |
| US10981875B2 (en) | 2016-12-09 | 2021-04-20 | Regents Of The University Of Minnesota | Quinolone-based compounds with anticancer activity |
| CN114539213A (zh) * | 2021-08-18 | 2022-05-27 | 广东工业大学 | 一种氟喹诺酮类化合物及其制备方法和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4774246A (en) * | 1984-01-26 | 1988-09-27 | Abbott Laboratories | Quinoline antibacterial compounds |
| JPS60163866A (ja) * | 1984-01-26 | 1985-08-26 | アボツト ラボラトリーズ | キノリン系抗菌性化合物 |
| JPS61251667A (ja) * | 1985-04-30 | 1986-11-08 | Otsuka Pharmaceut Co Ltd | ベンゾヘテロ環化合物 |
| GB8524662D0 (en) * | 1985-10-07 | 1985-11-13 | Fujisawa Pharmaceutical Co | Quinolone compounds |
| US5591744A (en) * | 1987-04-16 | 1997-01-07 | Otsuka Pharmaceutical Company, Limited | Benzoheterocyclic compounds |
| US4851418A (en) * | 1987-08-21 | 1989-07-25 | Warner-Lambert Company | Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent |
| JPH0348682A (ja) * | 1989-07-14 | 1991-03-01 | Yoshitomi Pharmaceut Ind Ltd | ピリドンカルボン酸化合物 |
| DE3934082A1 (de) * | 1989-10-12 | 1991-04-18 | Bayer Ag | Chinoloncarbonsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung als antivirale mittel |
| EP0911336B1 (de) * | 1996-02-27 | 2001-11-28 | Dainippon Pharmaceutical Co., Ltd. | Pyridoncarbonsäure-derivate und zwischenverbindungen für deren herstellung |
| PT897919E (pt) * | 1996-04-19 | 2004-11-30 | Wakunaga Pharma Co Ltd | Novos derivados do acido piridonacarboxilico ou seus sais e agentes anti-bacterianos contendo-os como ingrediente activo |
-
1997
- 1997-11-27 KR KR10-1999-7004195A patent/KR100516379B1/ko not_active Expired - Fee Related
- 1997-11-27 AT AT97946800T patent/ATE247089T1/de not_active IP Right Cessation
- 1997-11-27 DE DE69724140T patent/DE69724140T2/de not_active Expired - Lifetime
- 1997-11-27 JP JP52452398A patent/JP3448305B2/ja not_active Expired - Fee Related
- 1997-11-27 US US09/308,641 patent/US6136823A/en not_active Expired - Fee Related
- 1997-11-27 CA CA002271136A patent/CA2271136C/en not_active Expired - Fee Related
- 1997-11-27 WO PCT/JP1997/004326 patent/WO1998023592A1/ja not_active Ceased
- 1997-11-27 EP EP97946800A patent/EP0945435B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US6136823A (en) | 2000-10-24 |
| KR20000053224A (ko) | 2000-08-25 |
| CA2271136C (en) | 2008-11-25 |
| EP0945435B1 (de) | 2003-08-13 |
| WO1998023592A1 (en) | 1998-06-04 |
| CA2271136A1 (en) | 1998-06-04 |
| EP0945435A4 (de) | 1999-12-15 |
| JP3448305B2 (ja) | 2003-09-22 |
| EP0945435A1 (de) | 1999-09-29 |
| DE69724140D1 (de) | 2003-09-18 |
| KR100516379B1 (ko) | 2005-09-26 |
| DE69724140T2 (de) | 2004-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69724140D1 (de) | Pyridoncarbonsäurederivate oder ihre salze und diese als aktive bestandteile enthaltende medikamente | |
| NO20020968D0 (no) | Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav | |
| DE69604714D1 (de) | Stilbenderivate und diese enthaltende pharmazeutische Zusammensetzungen | |
| DE69725978D1 (de) | Chalcon-derivate und medikamente die diese enthalten | |
| ATE260255T1 (de) | 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate | |
| TR199801530T2 (xx) | VEGF �nhibit�rleri olarak kinazolin t�revleri. | |
| DE69716810D1 (de) | 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one | |
| DE69635996D1 (de) | Pharmazeutische zusammensetzungen mit hydroximsäurederivaten | |
| PT842923E (pt) | Derivados do pirrolo e composicoes medicinais | |
| ATE358484T1 (de) | Antidiabetische medikamente | |
| ATE145906T1 (de) | Benzamid-derivate | |
| DE69834500D1 (de) | Xanthinderivative zur behandlung von hirnischämie | |
| MD1560F2 (en) | Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses. | |
| ATE342266T1 (de) | 1-methylcarbapenemderivate | |
| DE69400352D1 (de) | 3- oder 4-Glykosyloxybenzopyranderivat und dieses enthaltende antiallergisches Mittel | |
| DE69908855D1 (de) | 9a, 11b-dehydro Derivative von 9-oxime-3-keto-6-0-methylerythromycin | |
| DE69426771D1 (de) | Dopaminreinkorporationshemmer zur behandlung des parkinsonschen syndroms |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |